Factors Associated With Breakdown In Patients With Pulmonary Tuberculosis In The Field
Factors Associated with Breakdown in Patients with Pulmonary Tuberculosis in the Field
Abstract
Introduction
Pulmonary tuberculosis (TB) is a serious global health problem that affects millions of people worldwide. In Indonesia, pulmonary TB is a major public health concern, with a high prevalence of cases in the country. One of the major challenges in the treatment of pulmonary TB is the high rate of treatment discontinuation, which can lead to increased risk of death, disease progression, and transmission to others. The purpose of this study was to identify the factors associated with treatment discontinuation in patients with pulmonary TB in Medan, Indonesia.
Background
Pulmonary TB is a bacterial infection that affects the lungs, and it is usually caused by the bacterium Mycobacterium tuberculosis. The disease is transmitted through the air when an infected person coughs, sneezes, or talks, and it can also be spread through contact with contaminated food or water. The symptoms of pulmonary TB include coughing, chest pain, weight loss, and fatigue.
Methodology
This study was conducted in several pulmonary TB service centers in Medan, Indonesia, from August 2013 to January 2014. The research design was analytic with a cross-sectional approach, and the study population consisted of 63 pulmonary TB patients who had stopped treatment and 63 category I pulmonary TB patients who had never broken treatment and had been declared cured as a comparison group. Data was collected through questionnaires and interviews.
Results
The results of the study showed that there was no significant difference between patients who broke up treatment and those who did not break up treatment (P> 0.05) based on sex, age group, and education level. However, there were some significant differences in the factors associated with treatment discontinuation. The results showed that the distance between the house to the health facility, the side effects of the drug, the feeling of feeling better, and the ignorance of the risk due to termination of treatment were significant factors in breaking medical treatment (p <0.05). The main cause of pulmonary TB patients who stop treatment was to feel healed (46.03%) and worsening the condition of the disease (31.74%).
Discussion
The results of this study are consistent with previous studies that have shown that treatment discontinuation in pulmonary TB patients is related to various factors, including socio-economic conditions, comorbidities, and HIV infections. The study highlights the importance of considering social and psychological factors that affect treatment compliance in pulmonary TB patients.
Conclusion
The success of treatment of pulmonary TB is very dependent on the patient's compliance with the treatment plan. Therefore, education about the importance of continuing treatment until it is declared cured is a crucial step that needs to be done. Reduction of distance to health facilities and providing information about side effects and the risk of stopping treatment can help increase patient compliance in undergoing therapy. Overall, understanding of the factors that affect breakdown is very important for the development of a more effective intervention strategy, which in turn can reduce the incidence and death of tuberculosis.
Factors Associated with Treatment Discontinuation in Pulmonary TB Patients
Introduction
Pulmonary TB is a serious global health problem that affects millions of people worldwide. In Indonesia, pulmonary TB is a major public health concern, with a high prevalence of cases in the country. One of the major challenges in the treatment of pulmonary TB is the high rate of treatment discontinuation, which can lead to increased risk of death, disease progression, and transmission to others. The purpose of this study was to identify the factors associated with treatment discontinuation in patients with pulmonary TB in Medan, Indonesia.
Background
Pulmonary TB is a bacterial infection that affects the lungs, and it is usually caused by the bacterium Mycobacterium tuberculosis. The disease is transmitted through the air when an infected person coughs, sneezes, or talks, and it can also be spread through contact with contaminated food or water. The symptoms of pulmonary TB include coughing, chest pain, weight loss, and fatigue.
Methodology
This study was conducted in several pulmonary TB service centers in Medan, Indonesia, from August 2013 to January 2014. The research design was analytic with a cross-sectional approach, and the study population consisted of 63 pulmonary TB patients who had stopped treatment and 63 category I pulmonary TB patients who had never broken treatment and had been declared cured as a comparison group. Data was collected through questionnaires and interviews.
Results
The results of the study showed that there was no significant difference between patients who broke up treatment and those who did not break up treatment (P> 0.05) based on sex, age group, and education level. However, there were some significant differences in the factors associated with treatment discontinuation. The results showed that the distance between the house to the health facility, the side effects of the drug, the feeling of feeling better, and the ignorance of the risk due to termination of treatment were significant factors in breaking medical treatment (p <0.05). The main cause of pulmonary TB patients who stop treatment was to feel healed (46.03%) and worsening the condition of the disease (31.74%).
Discussion
The results of this study are consistent with previous studies that have shown that treatment discontinuation in pulmonary TB patients is related to various factors, including socio-economic conditions, comorbidities, and HIV infections. The study highlights the importance of considering social and psychological factors that affect treatment compliance in pulmonary TB patients.
Conclusion
The success of treatment of pulmonary TB is very dependent on the patient's compliance with the treatment plan. Therefore, education about the importance of continuing treatment until it is declared cured is a crucial step that needs to be done. Reduction of distance to health facilities and providing information about side effects and the risk of stopping treatment can help increase patient compliance in undergoing therapy. Overall, understanding of the factors that affect breakdown is very important for the development of a more effective intervention strategy, which in turn can reduce the incidence and death of tuberculosis.
Factors Associated with Treatment Discontinuation in Pulmonary TB Patients: A Systematic Review
Introduction
Pulmonary TB is a serious global health problem that affects millions of people worldwide. In Indonesia, pulmonary TB is a major public health concern, with a high prevalence of cases in the country. One of the major challenges in the treatment of pulmonary TB is the high rate of treatment discontinuation, which can lead to increased risk of death, disease progression, and transmission to others. The purpose of this study was to identify the factors associated with treatment discontinuation in patients with pulmonary TB in Medan, Indonesia.
Background
Pulmonary TB is a bacterial infection that affects the lungs, and it is usually caused by the bacterium Mycobacterium tuberculosis. The disease is transmitted through the air when an infected person coughs, sneezes, or talks, and it can also be spread through contact with contaminated food or water. The symptoms of pulmonary TB include coughing, chest pain, weight loss, and fatigue.
Methodology
This study was conducted in several pulmonary TB service centers in Medan, Indonesia, from August 2013 to January 2014. The research design was analytic with a cross-sectional approach, and the study population consisted of 63 pulmonary TB patients who had stopped treatment and 63 category I pulmonary TB patients who had never broken treatment and had been declared cured as a comparison group. Data was collected through questionnaires and interviews.
Results
The results of the study showed that there was no significant difference between patients who broke up treatment and those who did not break up treatment (P> 0.05) based on sex, age group, and education level. However, there were some significant differences in the factors associated with treatment discontinuation. The results showed that the distance between the house to the health facility, the side effects of the drug, the feeling of feeling better, and the ignorance of the risk due to termination of treatment were significant factors in breaking medical treatment (p <0.05). The main cause of pulmonary TB patients who stop treatment was to feel healed (46.03%) and worsening the condition of the disease (31.74%).
Discussion
The results of this study are consistent with previous studies that have shown that treatment discontinuation in pulmonary TB patients is related to various factors, including socio-economic conditions, comorbidities, and HIV infections. The study highlights the importance of considering social and psychological factors that affect treatment compliance in pulmonary TB patients.
Conclusion
The success of treatment of pulmonary TB is very dependent on the patient's compliance with the treatment plan. Therefore, education about the importance of continuing treatment until it is declared cured is a crucial step that needs to be done. Reduction of distance to health facilities and providing information about side effects and the risk of stopping treatment can help increase patient compliance in undergoing therapy. Overall, understanding of the factors that affect breakdown is very important for the development of a more effective intervention strategy, which in turn can reduce the incidence and death of tuberculosis.
Factors Associated with Treatment Discontinuation in Pulmonary TB Patients: A Case Study
Introduction
Pulmonary TB is a serious global health problem that affects millions of people worldwide. In Indonesia, pulmonary TB is a major public health concern, with a high prevalence of cases in the country. One of the major challenges in the treatment of pulmonary TB is the high rate of treatment discontinuation, which can lead to increased risk of death, disease progression, and transmission to others. The purpose of this study was to identify the factors associated with treatment discontinuation in patients with pulmonary TB in Medan, Indonesia.
Background
Pulmonary TB is a bacterial infection that affects the lungs, and it is usually caused by the bacterium Mycobacterium tuberculosis. The disease is transmitted through the air when an infected person coughs, sneezes, or talks, and it can also be spread through contact with contaminated food or water. The symptoms of pulmonary TB include coughing, chest pain,
Frequently Asked Questions (FAQs) about Factors Associated with Breakdown in Patients with Pulmonary Tuberculosis in the Field
Q: What is pulmonary tuberculosis (TB)?
A: Pulmonary TB is a bacterial infection that affects the lungs, and it is usually caused by the bacterium Mycobacterium tuberculosis. The disease is transmitted through the air when an infected person coughs, sneezes, or talks, and it can also be spread through contact with contaminated food or water.
Q: What are the symptoms of pulmonary TB?
A: The symptoms of pulmonary TB include coughing, chest pain, weight loss, and fatigue. In some cases, patients may also experience fever, night sweats, and loss of appetite.
Q: Why is treatment discontinuation a major challenge in pulmonary TB?
A: Treatment discontinuation is a major challenge in pulmonary TB because it can lead to increased risk of death, disease progression, and transmission to others. When patients stop taking their medication, the bacteria can become resistant to treatment, making it harder to cure the disease.
Q: What are the factors associated with treatment discontinuation in pulmonary TB patients?
A: The factors associated with treatment discontinuation in pulmonary TB patients include distance between the house to the health facility, side effects of the drug, feeling of feeling better, and ignorance of the risk due to termination of treatment.
Q: What is the main cause of pulmonary TB patients who stop treatment?
A: The main cause of pulmonary TB patients who stop treatment is to feel healed (46.03%) and worsening the condition of the disease (31.74%).
Q: How can healthcare providers reduce treatment discontinuation in pulmonary TB patients?
A: Healthcare providers can reduce treatment discontinuation in pulmonary TB patients by providing education about the importance of continuing treatment until it is declared cured, reducing the distance to health facilities, and providing information about side effects and the risk of stopping treatment.
Q: What is the importance of considering social and psychological factors in treatment compliance in pulmonary TB patients?
A: Considering social and psychological factors in treatment compliance in pulmonary TB patients is important because these factors can affect a patient's ability to adhere to treatment. For example, a patient who is experiencing financial difficulties may be less likely to continue treatment if they are unable to afford the medication.
Q: What is the role of education in reducing treatment discontinuation in pulmonary TB patients?
A: Education plays a crucial role in reducing treatment discontinuation in pulmonary TB patients. By educating patients about the importance of continuing treatment until it is declared cured, healthcare providers can help patients understand the risks of stopping treatment and the benefits of completing treatment.
Q: What are the implications of treatment discontinuation in pulmonary TB patients?
A: The implications of treatment discontinuation in pulmonary TB patients are severe. Treatment discontinuation can lead to increased risk of death, disease progression, and transmission to others. It can also lead to the development of drug-resistant TB, which is a major public health concern.
Q: What can be done to reduce the incidence and death of tuberculosis?
A: To reduce the incidence and death of tuberculosis, healthcare providers can implement effective treatment strategies, such as directly observed therapy (DOT), and provide education and support to patients to help them adhere to treatment. Additionally, healthcare providers can work to reduce the stigma associated with TB and provide access to care for all patients, regardless of their ability to pay.
Q: What is the importance of understanding the factors that affect breakdown in pulmonary TB patients?
A: Understanding the factors that affect breakdown in pulmonary TB patients is important because it can help healthcare providers develop effective intervention strategies to reduce treatment discontinuation and improve patient outcomes. By understanding the factors that contribute to treatment discontinuation, healthcare providers can develop targeted interventions to address these factors and improve patient compliance with treatment.